Years ago when many of use began HRT we didn’t know what the long term effects might have been. Many of us were faced with an ignorant and biased medical profession, who also didn’t know.
Many of those doctors knew how difficult it was to find anyone who would prescribe HRT. These predatory doctors would charge outrageous office fees leaving many of us with no option but to self-medicate.
Not to mention the ‘gatekeeper’ therapist who would lead on clients for months, even years, with a vague notion that someday they might fit neatly into their concept of man or woman to deserve the ‘HRT letter’ to present to a prescribing doctor, if one could be found.
All the while those therapists would rake in the dough from hopeful cash-strapped transgender victims.
I hope that you haven’t experienced any combination of these unscrupulous providers during your trip down our road less taken, but if you have…..
All that is changing now. We are educating the medical profession and ending our victimization by greedy immoral therapists.
A groundbreaking study titled “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals” will help.
From the study:
Credit: A study by the Weinand JD, Safer JD, Hormone therapy in transgender adults is safe with
provider supervision; A review of hormone therapy sequelae for transgender individuals. The Accepted manuscript will appear in the Journal of Clinical & Translational Endocrinology (2015).
•We review the relative safety of hormone treatment for transgender individuals.
•Estrogen treatment for transgender women may increase risk of thrombosis.
•Androgen treatment for transgender men may increase risk of polycythemia.
•Hormone therapy has not been shown to increase transgender individuals’ cancer risk.
Current literature suggests HT is safe when followed carefully for certain risks. The greatest health concern for HT in transgender women is venous thromboembolism. HT among transgender men appears to cause polycythemia. Both groups experienced elevated fasting glucose. There is no increase in cancer prevalence or mortality due to transgender HT.
Although current data support the safety of transgender HT with physician supervision, larger, long-term studies are needed in transgender medicine.